Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Euphoria in the IPO market - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Dec 23, 1999

    Euphoria in the IPO market

    In what could be termed as a revival in the primary issue market, initial public offerings (IPOs) in recent months have evoked euphoric responses from investors - both retail and corporate. However, as compared to the boom in the early years of this decade, there are marked differences this time.

    There are key structural differences as compared to the IPO market boom in the first half of the decade. First is the widespread and easy availability of IPO financing, which has permitted investors to take on leverage while applying for new issues. A significant aspect is the narrow investor focus on issues of software, pharmaceutical and media companies. Another key difference this time is the participation of mutual funds in the IPO market. These factors have increased the liquidity in the market leading to large over subscriptions.

    The recent issues that have evoked a good response are TV18 (media) and Glenmark Pharma (Pharmaceuticals). While TV18 has been oversubscribed by 51 times, Glenmark has recorded an over subscription of over 55 times. Jointly, the two issues have evoked responses worth over Rs 54 bn. Even these amounts stand dwarfed against the HCL Technologies offering which managed to evoke a response in excess of Rs 200 bn.

    Although this may seem as 'irrational exuberance' to many, the quality of offer documents has infact substantially improved over those in the previous years. This is mainly due to the fact that the regulator, The Securities and Exchange Board of India, has taken numerous measures to prevent fraudulent companies from accessing capital markets via this route. The confidence level in the market has tremendously improved since the 1994 primary market debacle.

    Some factors that need to be considered are the effects of the secondary market on the IPO market and the possibility that some dud issues may enter the market. These two factors can have a critical bearing on the IPO boom. A decline in the secondary market could deal a deathblow to the IPO market as expectations of returns on listing of issues dramatically reduce.

    The euphoria is currently centred on the software, media and pharmaceutical sectors as the listed stocks in these sectors have recorded dramatic gains over the past few months. These gains cannot continue to grow indefinitely at rates recorded in recent months and this could lead to expectations being marked downwards in the near future. The other concern is the possibility of some dud issues entering the market. This could significantly alter the risk perceptions in the market, affecting even good issues.

    The course the stock markets take in the future is surely going to affect the fortunes of the IPO market. However, the possibility that some unscrupulous promoters would try to capitalise on this euphoria is what should be of prime concern for the regulator.



    Equitymaster requests your view! Post a comment on "Euphoria in the IPO market". Click here!


    More Views on News

    Insider Leaks Equitymaster Stock Picks (The 5 Minute Wrapup)

    Jul 25, 2017

    Equitymaster HQ has been infiltrated. Valuable stock ideas have been leaked. Who's responsible?

    Raymond and Other 'For Profit' Companies Who Don't Care about Shareholder Returns (The 5 Minute Wrapup)

    May 27, 2017

    What happens when minority shareholders are short-changed in the normal course of business?

    Why Commission Driven Model In Mutual Funds Should Be Eliminated... (Outside View)

    Feb 15, 2017

    PersonalFN believes SEBI has taken a step back-apparently in the admission of it going overboard with the regulations.

    This Book Changed How I Looked at the World of Man and Money (Vivek Kaul's Diary)

    Aug 24, 2016

    And here's your chance to claim a free copy of this book...

    The Developed World is Dying because of Demographics, Debt, and Deflation (Vivek Kaul's Diary)

    Aug 12, 2016

    And Why India's demographic dividend could turn out to be a doubtful debt...

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms